Plastic and Reconstructive Surgery • July 2017 C left lip with or without cleft palate occurs in approximately one in 500 to 700 live births worldwide, representing the most common congenital craniofacial anomaly in humans. 1 These malformations result in facial disfigurement, impaired feeding, and defective speech, and create psychological, emotional, and economic hardships for patients and their families. 2 Proper treatment of this deformity requires a multidisciplinary team consisting of pediatricians, plastic surgeons, geneticists, neurosurgeons, otolaryngologists, dentists, audiologists, speech-language pathologists, and psychologists. 1, 2 Mice share similar craniofacial morphologic development with humans and thus are commonly used to study embryonic processes. 3, 4 At gestational day 10.5 in mice (equivalent to the late fourth week in humans), the morphology of the midface, including the upper lip and primary palate, is gradually formed by fusion of the maxillary processes, medial nasal process, and lateral nasal process at the lambdoidal junction [3] [4] [5] ( Fig. 1 ). Cleft lip with or without cleft palate most often occurs without an identifiable cause (70 percent) and less frequently presents in association with other defects in syndromic forms caused by teratogenic exposure, chromosomal abnormalities, or single-gene mutations. 6, 7 Earlier studies identified a complex, genetically controlled, and tightly regulated molecular network that mediates craniofacial morphogenesis. 4 Previous reports show that the fusion at the midface lambdoidal junction is characterized by high expression of Wnt and Bmp genes, and Irf6 and p63 in both mice and humans, aberrations of which can lead to cleft lip with or without cleft palate. 4, 8, 9 Furthermore, among the genetic mechanisms that come into play, it has been demonstrated that the canonical Wnt signaling pathway controls a cascade of morphogenetic events [9] [10] [11] (Fig. 1) . [See Figure, Supplemental Digital Content 1, which shows the Wnt/β-catenin signaling pathway. In the absence of Wnt, cytoplasmic β-catenin is constantly degraded by the Axin complex, which is composed of the scaffolding protein Axin, adenomatous polyposis coli (APC), casein kinase 1 (CK1), and glycogen synthase kinase 3 (GSK3). CK1 and GSK3 sequentially phosphorylate the amino-terminal region of β-catenin, resulting in β-catenin ubiquitination and degradation. By preventing β-catenin from reaching the nucleus, the DNA-bound T-cell factor/lymphoid enhancer factor (TCF/LEF) protein family represses Wnt target genes. However, the binding of WNT ligand to the Frizzled (FZD) receptor and the lowdensity lipoprotein-related receptor protein (LRP) 5 or 6 co-receptor, and interaction of FZD with the cytoplasmic protein disheveled (DSH) lead to inactivation of the Axin/APC/GSK3β/CKI complex and stabilization of cytoplasmic β-catenin. β-Catenin then accumulates and travels to the nucleus to form complexes with T-cell factor/lymphoid enhancer factor and activates Wnt target gene expression, http://links.lww.com/PRS/C198.] Notably, we previously reported craniofacial defects in embryos with loss of the Pbx1 homeodomain protein. 12 We also established that genes involved in midfacial development (Pbx1, Pbx2, and Pbx3) co-localize in the developing frontonasal processes, maxillary process, and olfactory placode, wherein they are expressed at high levels in both the ectoderm and the mesenchyme, resulting in apoptosis of the epithelial lining at the lambdoidal junction and subsequent fusion of the underlying mesodermal tissue. Compound loss of function of Pbx genes results in unilateral or bilateral cleft lip with or without cleft palate 4 ( Fig. 2) . Disruption of the Pbx-directed Wnt9b/Wnt3a signaling pathway in the midfacial epithelium results in suppression of apoptosis at the midface lambdoidal junction, which in turn causes epithelial persistence and abnormal lip and palate fusion. 4 We developed a unique murine model with compound Pbx deficiency that exhibits fully penetrant cleft lip with or without cleft palate. Furthermore, we demonstrated partial rescue of clefting using genetic strategies to reconstitute Wnt canonical signaling in the cephalic ectoderm. 4 To date, no effective tissue repair of clefting has been conducted during fetal development in engineered animal models of cleft lip with or without cleft palate. Alternative options to correct clefting such as retroviral gene therapy to alter Wnt signaling are potentially dangerous, given the possibility of retroviral induction of oncogene activation. 13 To investigate the possibility of performing tissue repair of orofacial clefting at an early gestational age, we used our Pbx-deficient embryonic murine model and sought to develop a minimally invasive correction method by means of microsurgical implantation of Wnt9b-soaked collagen microspheres suitable for intrauterine repair. 
MATERIALS AND METHODS

Animals
Pbx1 
Serum-Free Media Preparation
A serum-free culture medium prepared from commercially available stem cell media supplements was used in this study.
14 Knockout serum replacement (Invitrogen, Carlsbad, Calif.), KnockOut Dulbecco's Modified Eagle Medium (Invitrogen), and Dulbecco's Modified Eagle Medium (Invitrogen) were used to maintain a consistent formulation for all embryos, as described previously. 14, 15 Culture medium was filter sterilized through a 0.22-mm filter into a 50-ml conical tube and allowed to equilibrate for at least 5 minutes at room temperature.
Preparation of Collagen Microspheres
Type I collagen was extracted from rat tails following an established method (Pel-Freez Biologicals, Rogers, Ark.). 16 Collagen microspheres were fabricated in sterile conditions using a method based on a modified emulsification process and a self-assembled collagen fiber reconstitution process. 17 One hundred collagen microspheres (diameter, 20 to 50 μm) were soaked in 50 µl (100 µg/ml) of Wnt9b protein (R&D Systems, Minneapolis, Minn.) at 37°C overnight in the Wnt9b solution and stored at 4°C.
Preparation of Whole-Embryo Culture System
Glass culture bottles and rubber bottle corks were sterilized by autoclaving. The roller culture chamber of a whole-embryo culture system (Ikemoto Rika, Tokyo, Japan) was sprayed with 70% alcohol and warmed to 37°C before starting the culture. 18 A gas cylinder containing a gas mixture of 95% oxygen and 5% carbon dioxide was connected to the rotating culture chamber, and the gas flow was adjusted to flow through the embryo culture setup at a rate of 50 to 75 cc/minute to ensure adequate oxygen supply to the embryos. The rotation speed of the drum was set at 20 rpm.
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Embryo Dissection and Culture
Wild-type and mutant female mice were assessed for vaginal plugs every morning, and when vaginal plugs were found, female mice were considered to be at gestational day 0.5. At gestational day 11.5, pregnant mice were killed as specified by institutional animal care and use committee guidelines. After the uterus was removed from the abdomen, embryos were dissected from the decidua and freed from maternal membranes. The embryonic head was then gently exteriorized from the yolk sac while maintaining the integrity of the embryonic vasculature with that of the yolk sac. Each embryo was assessed morphologically for stage-dependent characteristics such as head-fold development, somite development, and heart rate. Embryos were then placed in 2 ml of equilibrated culture medium in a sterile glass vial and placed in the rotator drum, at 37°C. 19 The embryos were cultured for 24 hours.
Microsurgical Implantation of Collagen Microspheres
Under a stereomicroscope, embryos at gestational day 11.5 were placed with their face up to expose the midface lambdoidal junction. Collagen microspheres either with or without Wnt9b were implanted within the midface lambdoidal junction on the left side of wild-type and Pbx-deficient embryos; the contralateral (right) side of each respective embryo remained unperturbed. After implantation, embryos were then placed in labeled rotator bottles by using a plastic Pasteur pipette and cultured at 37°C using the mixture of 95% oxygen and 5% carbon dioxide supplied at a constant rate. After 24 hours, each embryo was gently transferred to a Petri dish. Viability was assessed by observing the heartbeat, morphologic features, and transparency (dead embryos are usually opaque and can show hemorrhage or edema).
Assessment of Wnt9b Release from Collagen Microspheres
Thirty collagen microspheres soaked with Wnt9b were suspended in 100 μl of 1× phosphatebuffered saline in each sealed Eppendorf tube and incubated in a 37°C water bath. One hundred microliters of supernatant in each Eppendorf tube was withdrawn precisely at 30 minutes, 1 hour, 3 hours, 6 hours, 12 hours, and 24 hours. Western blotting was performed as described previously.
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Histology
Samples were fixed with 4% paraformaldehyde and then were dehydrated with sequential ethanol washes in a Vacuum Infiltration Processor (VIP Tek Tissue Processor; Sakura, Alphen aan den Rijn, The Netherlands), embedded in paraffin, and cut into 10-μm-thick sections. Hematoxylin and eosin staining was performed. Stained sections were imaged with an inverted microscope using bright-field microscopy (Olympus 1X71; Olympus America, Center Valley, Pa.).
Scanning Electron Microscopy
Embryos were fixed with 4% paraformaldehyde in 1× phosphate-buffered saline followed by osmium tetroxide and gradually dehydrated in ethanol. The embryos were critical pointdried under carbon dioxide and sputter-coated with 30-nm gold particles. Images were obtained using a scanning electron microscope with a fieldemission electron gun (LEO 1550; Carl Zeiss, Oberkochen, Germany). The observed rate of rescue was calculated dividing the area of the cleft from the treated side by the untreated side. Area sizes were measured using ImageJ (National Institutes of Health, Bethesda, Md.).
21
B-Galactosidase Assay/X-gal Staining
We evaluated Wnt9b canonical activity in the midface of Pbx compound mutants by using Wnt reporter (BAT-gal) mice. 22 Wnt9b-impregnated collagen microspheres were implanted in the foreheads of BAT-gal mice (a region of baseline low expression) and cultured for 24 hours. X-gal staining was performed as described previously.
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RESuLTS
On initial embryo dissection, wild-type mouse embryos at gestational day 11.5 exhibited 100 percent survival when transferred into culture as evidenced by visible normal heartbeat and circulation. In addition, after 24 hours of culture in the whole-embryo culture system, embryos at gestational day 12.5 showed normal growth and morphologic development of facial structures (Fig. 3) .
The type I collagen microspheres used in this study were shown to have a stable structure and a diameter between 20 and 50 μm (Fig. 4) . To demonstrate the feasibility of an ex vivo microsurgical approach using collagen microspheres as drug delivery vehicles, trypan blue-soaked microspheres were implanted at the midface lambdoidal junction in wild-type mice to assess the reliability of the microsphere to remain in the target area throughout the culture period (Fig. 5) . Approximately 95 percent of microspheres implanted in the gestational day-11.5 embryos remained within the lambdoidal junction after 24 hours in culture. 3 . morphologic development of wild-type embryos in our whole-embryo cultured system on removal at gestational day 11.5 compared with wild-type embryos removed immediately from the uterus at gestational day 12.5. normal upper lip development was noted in embryos cultured in our whole-embryo culture system.
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Microsurgical implantation of collagen microspheres at the lambdoidal junction in cultured Pbx mutant embryos did not impair overall midface morphogenesis and growth compared to those without microsphere implantation (p > 0.05). Furthermore, Wnt9b-soaked collagen microsphere implantation resulted in a significant rescue of the clefting defect on the implanted side (p < 0.05) (Figs. 6 and 7) . A total of 59 Pbx1 -/-, Pbx2 +/-embryos with fully penetrant cleft lip phenotype were analyzed in our study. Notably, there was comparable growth and morphologic development (aside from clefting) in Pbx mutant mouse embryos cultured in this whole-embryo culture system for 24 hours compared with wildtype control embryos.
Rescue was defined as a ratio of less than 50 percent in the area of clefting (complete 5 . implantation of trypan blue-soaked microspheres to study the orientation and the ability of the microsphere to stay implanted throughout culture. note that the trypan blue has been largely released from the microsphere after 24 hours in culture (a collagen microsphere is indicated by the red circle). MNP, medial nasal process; LNP, lateral nasal process; Mx, maxilla; Md, mandible. 
, Pbx2
+/-mutants at gestational day 12.5 after Wnt-soaked microsphere implantation at gestational day 11.5. Scanning electron microscopy (SEm) of gestational day-12.5 mouse embryos (frontal views): wild-type (left), Pbx1
+/-mutants (center and right). Pbx1/2 mutants after Wnt9b-soaked microsphere implantation at gestational day 11.5 exhibited a decrease in the extent of clefting (>50 percent) on the left implanted side (red circle) compared with the right untreated side (blue circle).
Fig. 7. area ratio of clefting in Pbx1
-/-, Pbx2 +/-mutants with or without implantation of microspheres. implantation of Wnt-soaked microspheres resulted in a significant reduction in area ratio of clefting, compared with blank microspheres and the unimplanted contralateral side (p < 0.05). Blank microsphere implantation did not affect the area ratio of clefting (p > 0.05) versus the unimplanted contralateral side. an area ratio of clefting (treated side-to-untreated side of bilateral cleft lip) less than 50 percent is considered a rescued cleft lip. red dots represent the rescued mouse embryos.
Plastic and Reconstructive Surgery • July 2017 or incomplete closure) comparing the treated side to the untreated/control side ( Table 1) . Sixteen of the 59 Pbx mutant embryos with orofacial clefting analyzed exhibited significant rescue, totaling an observed 27.1 percent rate of rescue. It has to be underscored that the rate of rescue after microsurgical implantation of Wnt9b-soaked collagen microspheres might be overestimated by 1.35 percent (a factor that equals the percentage of unilateral clefting 4 over the total percentage of observed rescue). This takes into consideration that compound Pbx mutant embryos display a fully penetrant cleft lip with or without cleft palate phenotype with an overall incidence of bilateral clefting of 95 percent and unilateral clefting of 2.4 percent for either right or left side. 4 Using the implantation protocol described above, in vivo experiments to study the spatial extent of action of Wnt expression in implanted BAT-gal embryos were also conducted. Given endogenous Wnt signaling at the lambdoidal junction of Wnt-reporter BAT-gal embryos, it was difficult to estimate the expression of exogenously delivered Wnt in this region. Thus, targeted delivery of Wnt9b was demonstrated by implantation of Wnt9b-soaked microspheres at the forehead (an area of low endogenous Wnt), resulting in augmented canonical Wnt signaling in the area surrounding the collagen microsphere compared with the contralateral side (Fig. 8) . To gauge the range of action and optimize the dose of Wnt protein released by the collagen microspheres, the release kinetics from Wnt9b-soaked microspheres was quantified using Western blotting. By 3 hours, nearly half of the of the loaded Wnt (approximately 50 ng/ microsphere) was released into the solution; by 6 hours, almost 90 percent had been released. [See Figure, Supplemental Digital Content 2, which shows the levels of Wnt9b released from Wnt9b-soaked collagen microspheres by using Western blotting. Similar to methods used in the in vivo experiments, an aliquot of 50 µl (100 µg/ml) of Wnt9b protein was used to soak 100 collagen microspheres. Thirty Wnt9b-soaked microspheres were suspended in 1× phosphatebuffered saline in each sealed Eppendorf tube and incubated in a 37°C for 30 minutes, 1 hour, 3 hours, 6 hours, 12 hours, and 24 hours. Analyses of band intensity were presented as the relative ratio of Wnt9b protein released from 30 microspheres to an appropriate Wnt9b solution at known concentration. Three hours after soaking of the collagen microspheres in the solution, nearly half of the loaded Wnt (approximately 50 ng/microsphere) was released into the solution; by 12 hours, almost two-thirds had been released. Control (Con), 10 μl (100 μg/ml) Wnt solution; *p < 0.05 versus control; #p > 0.05 versus control, http://links.lww.com/PRS/C199.]
DISCuSSION
Cleft lip with or without cleft palate has dramatic consequences for the affected child and their family, requiring many cycles of surgery, speech therapy, specialized orthodontics, and dentistry. 2, 4, 6, 7 Despite multiple interventions, patients with cleft lip with or without cleft palate are often left with significant sequelae, including visible scars, abnormal dentition, nasal deformity, lack of midfacial growth, and hypernasal speech, all of which can significantly impact the patient's future life and associated health care costs.
Presently, no single genetic lesion has been identified as a universal culprit for cleft lip with or without cleft palate, but it is understood that both genetic and environmental factors contribute to its cause. 2, 3, 5 Murine models of clefting have been widely used based on the fact that mice and humans share a similar craniofacial developmental process. 3, 4 and Pbx 11, 12 ) have been found to be crucial in initiating patterns of gene expression that result in morphologic changes in the developing face and head. In support of this evidence, previous findings have shown that mutations in the Wntp63-Irf6 regulatory network play a key role in the pathogenesis of cleft lip with or without cleft palate in humans and mice. 4 In a previous study, we successfully established a strong genetic interaction between Pbx and Wnt9b and demonstrated that Pbx homeoproteins directly control Wnt signaling. 4, 12 In our murine model, with simultaneous loss of multiple Pbx genes and consequent loss of function of Wnt/β-catenin pathway components, failure of apoptosis along the lambdoidal junction results in cleft lip with or without cleft palate. 4 In the present study, our aim was to develop a new microsurgical technique to deliver intrinsic growth factors that may be absent or reduced in cases of cleft lip with or without cleft palate. Whole embryos provide the tissue integrity and support appropriate for the tissue interactions that are crucial for timely occurrence of signaling mechanisms essential for different cellular processes during organogenesis. 6, 18 The serumfree culture medium used to culture midgestation stage wild-type embryos allowed for progressive growth and morphologic development for 24 hours, which permitted normal cellular behaviors (proliferation, migration, differentiation, and tissue interactions) comparable to those observed in embryos developing in utero.
14 In addition, mutant mouse embryos cultured for 24 hours under these defined conditions exhibited normal progression of frontonasal morphogenesis and development of the upper lip, which provided the possibility for evaluating and measuring the area of clefting.
Wnt, a potent stem cell-inducing growth factor, has been labeled as a therapeutic protein in regenerative medicine, even though it can be extremely deleterious if delivered in a high dose. 30, 31 However, targeted localization of Wnt-impregnated collagen microspheres to the midface lambdoidal junction as shown in this study does not raise serious concerns for global Wnt activation. Furthermore, the collagen microsphere carrier used did not alter or improve normal development at the lambdoidal junction. Therefore, our microsurgical technique offers the proof of concept for a minimally invasive approach at very early stages of development and defines a new potential method for fetal surgery to correct cleft lip with or without cleft palate.
The possibility for intrauterine correction of cleft lip with or without cleft palate would take advantage of the fact that fetal wound healing is phenotypically superior than adult or neonatal wound healing, [2] [3] [4] and thus fetal cleft lip with or without cleft palate surgery is an attractive surgical option. 32, 33 In support of this approach, several groups have used intrauterine repair as a way of preventing scarless healing.
2,34 Even though fetal Because this particular model requires intervention at day 10.5 of gestation in the mouse, which is equivalent to 4 weeks in the human fetus, there remain significant barriers prior to translation of this approach to cleft repair. However, with further investigation, fetal surgery may yet allow for scarless repair of cleft lip with or without cleft palate.
Our overall rate of rescue of 27.1 percent can be attributed to multiple factors. Undetectable injuries caused by the microsurgical procedure were inevitable, and even with a 100 percent survival rate, the growth status of each embryo could not be the same as in normal in utero development, given that minor but significant experimental variations occur when using the whole-embryo culture system. Further, although our microsphere delivery system did result in a localized elevation in Wnt activity, optimization of the release kinetics and of the dosage will be necessary to improve the efficacy of this technique.
Taking into account the benefits and risks mentioned above, microsurgical implantation of Wnt protein for extrauterine and even intrauterine cleft lip with or without cleft palate repair cannot yet be implemented for clinical applications. We will need to overcome significant technical limitations, and improve tissue engineering methods, to advance this approach from the laboratory to the clinical field.
CONCLuSIONS
In summary, we have demonstrated a proofof-concept approach to rescue cleft lip with or without cleft palate using exogenously delivered Wnt protein to restore critical developmental programs. Furthermore, our novel ex vivo wholeembryo culture system can be used to open new avenues toward unconventional and innovative prenatal interventions for patients with cleft lip with or without cleft palate, and provide new solutions toward future prenatal repair approaches to correct other congenital head and neck disorders. 
